A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants.
Adebola AjaoAustin CosgroveEfe EworukeMohamed MohamoudRongmei ZhangOren ShapiraJoy KolonoskiJohn G ConnollyPublished in: Pharmacoepidemiology and drug safety (2022)
We did not find significant evidence of differential CSVV risk in pair-wise comparisons of DOACs and warfarin.